Global Colorectal Cancer Screening Test Market 2026 by Company, Regions, Type and Application, Forecast to 2032
Description
According to our (Global Info Research) latest study, the global Colorectal Cancer Screening Test market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
A colorectal cancer screening test refers to a diagnostic procedure aimed at detecting early signs of colorectal cancer or precancerous conditions in individuals without symptoms. These screening tests include various methods such as stool-based tests, imaging tests like colonoscopy, sigmoidoscopy, and virtual colonoscopy, as well as blood tests for tumor markers. The primary goal of colorectal cancer screening is to identify abnormalities in the colon or rectum at an early stage when cancer is most treatable, allowing for timely intervention and improved patient outcomes.
The market for colorectal cancer screening tests is witnessing significant growth due to increasing awareness about the importance of early detection and the rising prevalence of colorectal cancer worldwide. Governments, healthcare organizations, and advocacy groups are actively promoting colorectal cancer screening programs to reduce mortality rates and healthcare costs associated with late-stage diagnoses. Stool-based tests, such as fecal occult blood tests (FOBT) and fecal immunochemical tests (FIT), are gaining popularity due to their non-invasive nature and convenience for patients. Additionally, advancements in imaging technologies and blood-based biomarkers are improving the accuracy and efficacy of colorectal cancer screening tests. However, challenges such as patient compliance, access to screening facilities, and reimbursement issues hinder market growth. Nonetheless, with ongoing research and development efforts aimed at enhancing test accuracy, expanding screening programs, and improving patient awareness, the colorectal cancer screening test market is expected to continue growing, particularly in regions with aging populations and increasing healthcare infrastructure.
This report is a detailed and comprehensive analysis for global Colorectal Cancer Screening Test market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Colorectal Cancer Screening Test market size and forecasts, in consumption value ($ Million), 2021-2032
Global Colorectal Cancer Screening Test market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Colorectal Cancer Screening Test market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Colorectal Cancer Screening Test market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Colorectal Cancer Screening Test
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Colorectal Cancer Screening Test market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novigenix SA, Eiken Chemical Co., Ltd., Clinical Genomics Pathology, Inc., Exact Sciences Corporation, Epigenomics AG, BioMerieux S.A., Olympus Corporation, Sysmex Corporation, Fujifilm Holdings Corporation, Siemens Healthineers AG (Siemens AG), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Colorectal Cancer Screening Test market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Fecal Immunochemical Test (FIT)
Fecal Occult Blood Test (FOBT)
Stool-DNA Test
Other
Market segment by Application
Hospitals & Clinics
Clinical Laboratories
Diagnostic Imaging Centres
Others
Market segment by players, this report covers
Novigenix SA
Eiken Chemical Co., Ltd.
Clinical Genomics Pathology, Inc.
Exact Sciences Corporation
Epigenomics AG
BioMerieux S.A.
Olympus Corporation
Sysmex Corporation
Fujifilm Holdings Corporation
Siemens Healthineers AG (Siemens AG)
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Colorectal Cancer Screening Test product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Colorectal Cancer Screening Test, with revenue, gross margin, and global market share of Colorectal Cancer Screening Test from 2021 to 2026.
Chapter 3, the Colorectal Cancer Screening Test competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Colorectal Cancer Screening Test market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Colorectal Cancer Screening Test.
Chapter 13, to describe Colorectal Cancer Screening Test research findings and conclusion.
A colorectal cancer screening test refers to a diagnostic procedure aimed at detecting early signs of colorectal cancer or precancerous conditions in individuals without symptoms. These screening tests include various methods such as stool-based tests, imaging tests like colonoscopy, sigmoidoscopy, and virtual colonoscopy, as well as blood tests for tumor markers. The primary goal of colorectal cancer screening is to identify abnormalities in the colon or rectum at an early stage when cancer is most treatable, allowing for timely intervention and improved patient outcomes.
The market for colorectal cancer screening tests is witnessing significant growth due to increasing awareness about the importance of early detection and the rising prevalence of colorectal cancer worldwide. Governments, healthcare organizations, and advocacy groups are actively promoting colorectal cancer screening programs to reduce mortality rates and healthcare costs associated with late-stage diagnoses. Stool-based tests, such as fecal occult blood tests (FOBT) and fecal immunochemical tests (FIT), are gaining popularity due to their non-invasive nature and convenience for patients. Additionally, advancements in imaging technologies and blood-based biomarkers are improving the accuracy and efficacy of colorectal cancer screening tests. However, challenges such as patient compliance, access to screening facilities, and reimbursement issues hinder market growth. Nonetheless, with ongoing research and development efforts aimed at enhancing test accuracy, expanding screening programs, and improving patient awareness, the colorectal cancer screening test market is expected to continue growing, particularly in regions with aging populations and increasing healthcare infrastructure.
This report is a detailed and comprehensive analysis for global Colorectal Cancer Screening Test market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Colorectal Cancer Screening Test market size and forecasts, in consumption value ($ Million), 2021-2032
Global Colorectal Cancer Screening Test market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Colorectal Cancer Screening Test market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Colorectal Cancer Screening Test market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Colorectal Cancer Screening Test
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Colorectal Cancer Screening Test market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novigenix SA, Eiken Chemical Co., Ltd., Clinical Genomics Pathology, Inc., Exact Sciences Corporation, Epigenomics AG, BioMerieux S.A., Olympus Corporation, Sysmex Corporation, Fujifilm Holdings Corporation, Siemens Healthineers AG (Siemens AG), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Colorectal Cancer Screening Test market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Fecal Immunochemical Test (FIT)
Fecal Occult Blood Test (FOBT)
Stool-DNA Test
Other
Market segment by Application
Hospitals & Clinics
Clinical Laboratories
Diagnostic Imaging Centres
Others
Market segment by players, this report covers
Novigenix SA
Eiken Chemical Co., Ltd.
Clinical Genomics Pathology, Inc.
Exact Sciences Corporation
Epigenomics AG
BioMerieux S.A.
Olympus Corporation
Sysmex Corporation
Fujifilm Holdings Corporation
Siemens Healthineers AG (Siemens AG)
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Colorectal Cancer Screening Test product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Colorectal Cancer Screening Test, with revenue, gross margin, and global market share of Colorectal Cancer Screening Test from 2021 to 2026.
Chapter 3, the Colorectal Cancer Screening Test competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Colorectal Cancer Screening Test market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Colorectal Cancer Screening Test.
Chapter 13, to describe Colorectal Cancer Screening Test research findings and conclusion.
Table of Contents
90 Pages
- 1 Market Overview
- 2 Company Profiles
- 3 Market Competition, by Players
- 4 Market Size Segment by Type
- 5 Market Size Segment by Application
- 6 North America
- 7 Europe
- 8 Asia-Pacific
- 9 South America
- 10 Middle East & Africa
- 11 Market Dynamics
- 12 Industry Chain Analysis
- 13 Research Findings and Conclusion
- 14 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
